Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine

Transplant Proc. 1996 Dec;28(6):3270-1.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Animals
  • Antigens, CD
  • Antigens, Differentiation / therapeutic use*
  • CTLA-4 Antigen
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Graft Survival / drug effects
  • Graft Survival / immunology*
  • Immunoconjugates*
  • Immunosuppressive Agents / therapeutic use*
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred Strains
  • Polyenes / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use
  • Sirolimus
  • Skin Transplantation / immunology*
  • Time Factors
  • Transplantation, Homologous

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • Ctla4 protein, mouse
  • Immunoconjugates
  • Immunosuppressive Agents
  • Polyenes
  • Recombinant Fusion Proteins
  • Abatacept
  • Cyclosporine
  • Sirolimus